UNIVERSITY OF KANSAS

Rev. Luke Doyle, a three-year priest, became director and chaplain at St. Lawrence Catholic Center at the University of Kansas in July. Students like Ciara Sumpter appreciate his efforts in transitioning smoothly. Doyle, originally from Topeka, changed his career path from medicine to priesthood, ordained in 2021, and now enjoys his role as a spiritual father to students.

The University of Kansas’ Gateway District Project faces challenges with Phase II, including unexpected east stands remodeling and potential impacts on students, such as reduced seating and new on-campus housing. Funding for Phase I, now $448 million, includes private donations, state grants, and debt, with no estimates yet for Phase II. The project aims to open in August 2025.

Bristol Myers Squibb and 2seventy bio halted the KarMMa-9 trial due to enrollment challenges, despite efforts to facilitate recruitment. Advances in induction therapies have reduced the eligible patient population for the trial. However, ide-cel (Abecma) received FDA approval for expanded use in relapsed/refractory multiple myeloma after two prior lines of therapy, based on positive results from the KarMMa-3 trial.